Overview

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

Status:
Not yet recruiting
Trial end date:
2023-03-28
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of HRS-7085.
Phase:
Phase 1
Details
Lead Sponsor:
Atridia Pty Ltd.